Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

OBJECTIVE: Short-term efficacy of induction therapy with intravenous immunoglobulin (Ig) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) is well established. However, data of previous studies on maintenance therapy were limited up to 24-week treatment period. We aimed to in...

詳細記述

保存先:
書誌詳細
出版年:J Neurol Neurosurg Psychiatry
主要な著者: Kuwabara, Satoshi, Mori, Masahiro, Misawa, Sonoko, Suzuki, Miki, Nishiyama, Kazutoshi, Mutoh, Tatsuro, Doi, Shizuki, Kokubun, Norito, Kamijo, Mikiko, Yoshikawa, Hiroo, Abe, Koji, Nishida, Yoshihiko, Okada, Kazumasa, Sekiguchi, Kenji, Sakamoto, Ko, Kusunoki, Susumu, Sobue, Gen, Kaji, Ryuji
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2017
主題:
Neuromuscular
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5629934/
https://ncbi.nlm.nih.gov/pubmed/28768822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2017-316427
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料